Back to Top Skip to main content

World AIDS Day puts spotlight on landmark DoD study

Dr. John Mascola, director of the National Institutes of Health Vaccine Research Center, discusses HIV vaccine progress at the Walter Reed Army Institute of Research, Nov. 26, during a World AIDS Day commemoration.  (U.S. Army photo) Dr. John Mascola, director of the National Institutes of Health Vaccine Research Center, discusses HIV vaccine progress at the Walter Reed Army Institute of Research, Nov. 26, during a World AIDS Day commemoration. (U.S. Army photo)

Recommended Content:

Immunization Healthcare | Research and Innovation | Global Health Engagement

The Walter Reed Army Institute of Research (WRAIR) hosted a World AIDS Day event Tuesday, Nov. 26, highlighting advances in DoD-led HIV research and celebrating the 10th anniversary of the Army-led RV144 HIV vaccine study.

WRAIR’s Military HIV Research Program or MHRP headed the RV144 study, the first-ever – and only to-date – clinical trial to demonstrate that an HIV vaccine regimen was safe and modestly effective in preventing HIV infection. The study sought to determine what methods could be used to lower risk of contracting the disease.

The RV144 trial represented a massive undertaking for the Army and serves as a model of international and interagency collaboration. It involved more than 16,000 adult volunteers and a large network of partners who still work with WRAIR today, including the Thai Ministry of Public Health; the National Institute of Allergy and Infectious Diseases – part of the National Institutes of Health; and Sanofi Pasteur.

In 2009, the Army announced that the study’s investigational prime-boost vaccine regimen lowered the rate of HIV infection by 31.2 percent. These results, although modest, gave the global community hope that a vaccine to prevent HIV infection is possible at a time when such an achievement seemed elusive.

“RV144 was the light at the time in the field, without which we may have given up,” said Dr. John Mascola, director of the National Institutes of Health Vaccine Research Center and the featured speaker at WRAIR’s World AIDS Day event. “In the last 10 years of HIV vaccine progress, RV144 is the anchor.”

The landmark trial continues to provide scientific direction to help guide vaccine development and testing. RV144 and its follow-on trials allowed researchers to discover of risk factors, provide targets for optimizing vaccine boosting, and form a foundation for three HIV vaccine candidates currently undergoing efficacy testing. A video featuring many prominent HIV researchers who were involved with RV144 was shown at the World AIDS Day event.

Also at the event, Lt. Gen (Ret.) Eric B. Schoomaker, 42nd surgeon general of the United States Army and former commanding general of the United States Army Medical Command, highlighted the military’s earliest contributions to HIV research, which include the development of a disease staging system and promoting the finding that HIV can be transmitted heterosexually. The military’s HIV research efforts were consolidated in 1986 with the establishment of MHRP.

MHRP’s initial mission was to advance an HIV vaccine to protect service members and the global community from HIV, but has since expanded beyond vaccine development to include cure research and prevention and treatment services in Africa under the President’s Emergency Plan for AIDS Relief or PEPFAR. Via PEPFAR initiatives, WRAIR provides life-saving antiretroviral therapy to more than 350,000 people living with HIV in sub-Saharan Africa, which contributes to global health security.

WRAIR supports PEPFAR activities within military and civilian communities in four countries where it conducts research (Nigeria, Tanzania, Uganda, and Kenya), which strengthens community trust and provides an ethical framework for clinical studies. The Department of Defense HIV/AIDS Prevention Program, led by the U.S. Navy, is responsible for assisting foreign military partners with the development and implementation of military-specific HIV/AIDS prevention and treatment programs in more than 55 countries around the globe, also supported by PEPFAR.

“Those countries that partner with us on PEPFAR have a 40-percent decrease in violence and a 40-increase in political stability,” said WRAIR Commander Army Col. Deydre Teyhen. “So we say that soldier health is world health. But in fighting HIV/AIDS, WRAIR researchers are also working to advance world peace.”

More information can be found on the RV144 HIV Trial web page.

You also may be interested in...

COVID-19 leads to innovation in military health care practices

Article
7/1/2020
Man in lab coat and mask prepares sample for COVID-19 testing.

MHS thinks outside of the box to bring care to patients during pandemic

Recommended Content:

Coronavirus | Research and Innovation

Navy Care virtual health app wins innovation award

Article
6/12/2020
Soldier in front of a computer monitor

Navy Care offers a live, virtual visit with a clinician — from the patient's smartphone, laptop, or computer.

Recommended Content:

Health Readiness | Research and Innovation | Technology

Air Force International Health Specialists bring experience to pandemic response

Article
6/12/2020
Two men in masks...one in military uniform, the other casually dressed

Stepping out of your comfort zone and being part of the larger DOD mission is crucial to grow as a military medic.

Recommended Content:

Coronavirus | Global Health Engagement | Global Health Engagement

WRNMMC Recognizes Medical Researchers

Article
6/10/2020
Military personnel stand in front of window holding their awards

15 winners of Research & Innovation Month awards announced

Recommended Content:

Research and Innovation

WRNMMC Operates Drive-Up Immunization Clinic

Article
6/3/2020
Nurse giving a shot to a girl; both wearing masks

Parents and others (are encouraged) to maintain their immunization health during COVID-19.

Recommended Content:

Coronavirus | Immunization Healthcare

Recommendations for Mass Immunization Events During Pandemic Conditions

Fact Sheet
5/27/2020

During pandemic conditions, planners of mass immunization events need to consider additional measures to minimize risk of COVID-19 or similar infectious disease transmission.

Recommended Content:

Immunization Healthcare

Foreign liaison officers bring new perspective to MHS

Article
5/26/2020
Image of three men talking to each other

Medical information exchange aids in better care everywhere

Recommended Content:

Global Health Engagement | Coronavirus | Global Health Engagement

BAMC infectious disease doc aids Guam's COVID response

Article
5/14/2020
Image of soldier standing, surrounded by tropical water

The Navy has since undertaken an aggressive mitigation plan of isolating, quarantining, and treating affected Sailors to keep the ship prepared to execute its mission.

Recommended Content:

Coronavirus | Global Health Engagement | Global Health Engagement

Mobility Airmen conduct historic first aeromedical evacuation mission using Transport Isolation System

Article
5/4/2020
Image of three people exiting an aircraft

The TIS is an infectious disease containment unit designed to minimize risk to aircrew, medical attendants, and the airframe.

Recommended Content:

Coronavirus | Global Health Engagement | Global Health Engagement

CDC maintains childhood immunization guidelines during COVID-19

Article
5/1/2020
A child receives a vaccine during a visit to the clinic.

What you need to know about getting your child vaccinated

Recommended Content:

Coronavirus | Immunization Healthcare | Vaccine-Preventable Diseases

Immunization Tool Kit 9th Edition

Publication
4/30/2020

A practical reference that facilitates and enhances the global delivery of quality immunization healthcare to Department of Defense (DoD) beneficiaries and employees. The Defense Health Agency Immunization Healthcare Division (DHA-IHD) publishes the Immunization Tool Kit based on national recommendations, evidenced-based, peer-reviewed published medical literature, and clinical practice guidelines.

Recommended Content:

Immunization Healthcare

Amid COVID-19, seasonal influenza still a threat to force readiness

Article
4/29/2020
Hospital Corpsman administers a flu shot to a navy officer.

New Southern Hemisphere flu vaccine available May 2020

Recommended Content:

Coronavirus | Influenza Summary and Reports | Immunization Healthcare | Vaccine-Preventable Diseases | Influenza, Southern Hemisphere

A look into the future: Embedded Health Engagement Teams

Article
4/22/2020
Female soldier teaching a class

The exercise promotes bilateral cooperation by providing opportunities for U.S. and partner nation military engineers, medical personnel and support staff to work and train side by side.

Recommended Content:

Global Health Engagement | Global Health Engagement

DHA IPM 20-002: Southern Hemisphere Influenza Vaccination Program

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), establishes the Defense Health Agency’s (DHA) procedures to implement instructions, assign responsibilities, and prescribe procedures for the Southern Hemisphere Influenza Vaccination Program. All Active Duty, Selected Reserve, and National Guard members receive an annual influenza vaccination. Personnel who are traveling to, conducting a permanent change of station to, or are located in the Southern Hemisphere will receive the Southern Hemisphere influenza vaccine or obtain an exemption (e.g., medical or administrative) in accordance with guidance in paragraph 6.a. of Attachment 2. Military personnel residing in the Southern Hemisphere who have received the Southern Hemisphere influenza vaccine in accordance with Appendix 1, meet the annual influenza immunization requirement.

Coronavirus: What you need to know

Article
3/6/2020
A Guardsmen with the 341st Military Intelligence Battalion conducts translation work on a safety message regarding the best practices for avoiding the novel coronavirus for the Washington Department of Health on Feb. 9, 2020 at the Information Operations Readiness Center, Joint Base Lewis-McChord, Wash. (Courtesy Photo)

Although news stories and images contain many reports of people wearing surgical masks to ward off the virus, that's not recommended

Recommended Content:

Global Health Engagement | Public Health | Coronavirus | Coronavirus
<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 17

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.